CLINICAL_TRIALS
trial_result
· 2013-08-12
Clinical Trial Update: Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders [Phase 3]
Summary
Amgen completed a Phase 3 trial evaluating the efficacy and safety of HPN-100 in adults with urea cycle disorders, with results published in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Urea Cycle Disorders | Phase 3 | Status: COMPLETED | Results posted: 2013-08-12